FDA Inspection
KLEB, IncKLEB, Inc – FDA Inspection, Sep 16, 2010
Record Details
This FDA Inspection record concerns KLEB, Inc, with an inspection on September 16, 2010, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- KLEB, Inc
- Inspection Date
- September 16, 2010
- Product Type
- Biologics
View Company Profile
ID · da6ccf74-e86b-4edf-a4f2-f9737367ead7
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 680875
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of KLEB, Inc
5| Date | Classification | Office | Project area |
|---|---|---|---|
| February 23, 2022 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| December 19, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| December 8, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| October 30, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| November 9, 2012 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for KLEB, Inc
- FDA Inspection 1163378 - 2022-02-23
- FDA Inspection 1076519 - 2018-12-19
- FDA Inspection 993737 - 2016-12-08
- FDA Inspection 902025 - 2014-10-30
- FDA Inspection 806766 - 2012-11-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.